Acasti Pharma Appoints Healthcare Industry Leader Michael

LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announces that it...

Related Keywords

Quebec ,Canada ,United States ,Roddy Carter ,Michaell Derby ,Johns Hopkins University ,Norphan Pharmaceuticals ,Company Nasdaq ,Drug Administration ,Paxmedica Inc ,York University Stern School Of Business ,Acasti Pharma Inc ,Castle Creek Pharmaceuticals ,Tardimed Sciences ,University Of Rochester ,Marathon Pharmaceuticals ,Anker Pharmaceuticals ,Timber Pharmaceuticals Inc ,Executive Chairman ,Centerstone Partners ,New York University ,Stern School ,Beneficial Hodson ,Orphan Drug Designation ,Subarachnoid Hemorrhage ,Postherpetic Neuralgia ,Tsx Venture Exchange Acst ,Acasti Pharma ,Nc ,Cst ,